Expand ADCT Menu
ADCT MENU

ADCT Latest Press Releases

-- April 1, 2026 --

ADC Therapeutics Announces New Employee Inducement Grant PRNewswire 4:05 PM

-- March 10, 2026 --

ADC Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Operational Update PRNewswire 7:30 AM

-- March 3, 2026 --

ADC Therapeutics to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 10, 2026 PRNewswire 7:15 AM

-- March 2, 2026 --

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan PRNewswire 4:05 PM

-- February 24, 2026 --

ADC Therapeutics to Participate in March Investor Conferences PRNewswire 7:15 AM

-- February 23, 2026 --

ADC Therapeutics Announces Amended HealthCare Royalty Financing Agreement PRNewswire 7:15 AM

-- February 2, 2026 --

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan PRNewswire 4:05 PM

-- January 22, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT PRNewswire 10:00 AM

-- January 15, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT PRNewswire 10:00 AM

-- January 13, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT Globe Newswire 4:58 PM

-- January 8, 2026 --

ADC Therapeutics Provides Preliminary Fourth Quarter and Full Year 2025 Revenue and Cash Estimates and Recent Corporate Updates PRNewswire 4:05 PM
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT PRNewswire 10:00 AM
ADC Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference PRNewswire 7:15 AM

-- January 6, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT Globe Newswire 11:56 AM

-- January 2, 2026 --

ADC Therapeutics Announces New Employee Inducement Grant PRNewswire 4:05 PM

-- January 1, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT PRNewswire 10:00 AM

-- December 30, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT Globe Newswire 12:50 PM

-- December 11, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT PRNewswire 10:00 AM

-- December 3, 2025 --

ADC Therapeutics Announces Updated Data from LOTIS-7 Phase 1b Clinical Trial of ZYNLONTA in Combination with Bispecific Antibody Supporting Potential Best-in-Class Regimen in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma PRNewswire 7:30 AM

-- December 2, 2025 --

ADC Therapeutics to Provide Update on LOTIS-7 Clinical Trial PRNewswire 4:05 PM

-- December 1, 2025 --

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan PRNewswire 4:05 PM

-- November 10, 2025 --

ADC Therapeutics Reports Third Quarter 2025 Financial Results and Provides Operational Update PRNewswire 7:30 AM
Market Data Delayed 15 Minutes